Harmon Killebrew: “My battle with esophageal cancer is coming to an end”

28 Comments

Hall of Famer and Twins great Harmon Killebrew has entered into hospice care following unsuccessful treatments for esophageal cancer and issued a very sad and equally brave statement:

It is with profound sadness that I share with you that my continued battle with esophageal cancer is coming to an end. With the continued love and support of my wife, Nita, I have exhausted all options with respect to controlling this awful disease. My illness has progressed beyond my doctors’ expectation of cure.

I have spent the past decade of my life promoting hospice care and educating people on its benefits. I am very comfortable taking this next step and experiencing the compassionate care that hospice provides. I am comforted by the fact that I am surrounded by my family and friends. I thank you for the outpouring of concern, prayers and encouragement that you have shown me. I look forward to spending my final days in comfort and peace with Nita by my side.

Damn.

Devastating news, especially since the initial reports about his treatment were so encouraging months ago. Killebrew is one of the greatest power hitters in baseball history, ranking fifth all time with 573 homers when he retired in 1975, but is also universally regarded as one of the nicest superstars of all time and is beloved by Twins fans and Minnesotans. Here’s hoping he finds some peace in his final days.

The Red Sox seem content to let Craig Kimbrel sign elsewhere

Getty Images
1 Comment

LAS VEGAS — Red Sox president Dave Dombrowski strongly signaled that the team was unlikely to re-sign Craig Kimbrel, telling the assembled Boston media contingent that, “we’re not looking to make a per se big expenditure in that area.” Referring to the bullpen.

Kimbrel, who saved 42 games for the World Series champs, was recently reported to be seeking a six-year contract. I doubt he gets that, but he’ll get a pretty big deal nonetheless, and the Sox obviously feel like they can manage with a cheaper option in the back of the bullpen.